Getting to the heart of the matter: cardiac involvement in transthyretin-related amyloidosis. - Suppr | 超能文献

Getting to the heart of the matter: cardiac involvement in transthyretin-related amyloidosis.

作者信息

Zeldenrust Steven R, Cooper Leslie T

出版信息

Eur Heart J. 2013 Feb;34(7):483-5. doi: 10.1093/eurheartj/ehs238. Epub 2012 Aug 26.

DOI:10.1093/eurheartj/ehs238

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Getting to the heart of the matter: cardiac involvement in transthyretin-related amyloidosis.

Eur Heart J. 2013 Feb;34(7):483-5. doi: 10.1093/eurheartj/ehs238. Epub 2012 Aug 26.

2

Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective.遗传性转甲状腺素蛋白相关淀粉样变性病仅有心脏表型的疾病特征和鉴别诊断：意大利视角。

Eur Heart J. 2013 Feb;34(7):520-8. doi: 10.1093/eurheartj/ehs123. Epub 2012 Jun 28.

3

Transthyretin amyloidosis: a phenocopy of hypertrophic cardiomyopathy.转甲状腺素蛋白淀粉样变性：肥厚型心肌病的表型模拟。

Amyloid. 2017 Jun;24(2):87-91. doi: 10.1080/13506129.2017.1322573. Epub 2017 May 5.

4

Genetically confirmed transthyretin amyloidosis primarily diagnosed as hypertrophic cardiomyopathy.基因确诊的转甲状腺素蛋白淀粉样变性病最初被诊断为肥厚型心肌病。

Pol Arch Intern Med. 2022 Feb 28;132(2). doi: 10.20452/pamw.16163. Epub 2021 Dec 3.

5

Amyloid heart disease mimicking hypertrophic cardiomyopathy.酷似肥厚型心肌病的淀粉样变心脏病

J Intern Med. 2005 Sep;258(3):225-30. doi: 10.1111/j.1365-2796.2005.01522.x.

6

Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness.在左心室壁增厚的患者中遗传性转甲状腺素蛋白淀粉样心肌病的患病率和临床表型。

Eur Heart J. 2016 Jun 14;37(23):1826-34. doi: 10.1093/eurheartj/ehv583. Epub 2015 Nov 3.

7

Characterization of untyped cardiac amyloidosis by mass spectrometry in a patient with Gly6Ser transthyretin polymorphism in fatal cardiogenic shock.在一名因致命性心源性休克而具有Gly6Ser转甲状腺素蛋白多态性的患者中，通过质谱法对未分型心脏淀粉样变性进行特征分析。

Arch Cardiovasc Dis. 2014 Dec;107(12):706-8. doi: 10.1016/j.acvd.2012.09.008. Epub 2013 Sep 23.

8

Chinese familial transthyretin amyloidosis with vitreous involvement is associated with the transthyretin mutation Gly83Arg: a case report and literature review.伴有玻璃体受累的中国家族性转甲状腺素蛋白淀粉样变性与转甲状腺素蛋白突变Gly83Arg相关：病例报告及文献综述

Amyloid. 2014 Jun;21(2):140-2. doi: 10.3109/13506129.2014.892871. Epub 2014 Mar 6.

9

Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-familial Amyloidosis.细胞外容量可检测转甲状腺素蛋白家族性淀粉样变性中的淀粉样心肌病，并与神经功能障碍相关。

Rev Esp Cardiol (Engl Ed). 2016 Oct;69(10):923-930. doi: 10.1016/j.rec.2016.02.027. Epub 2016 Jun 10.

10

[Familial transthyretin amyloidosis with Gly47Arg mutation and cardiac involvement: a case report].

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Sep;42(9):784-5.

引用本文的文献

1

Kidney Disease in Systemic Amyloidosis: A Review of Amyloid, Amyloid Serum A Protein, Leukocyte Chemotactic Factor 2, and Transthyretin Amyloid.系统性淀粉样变性中的肾脏疾病：淀粉样蛋白、血清淀粉样A蛋白、白细胞趋化因子2及转甲状腺素蛋白淀粉样变的综述

Kidney360. 2024 Dec 1;5(12):1925-1937. doi: 10.34067/KID.0000000600. Epub 2024 Oct 2.

2

Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy.口服治疗用于治疗转甲状腺素相关淀粉样心肌病。

Int J Mol Sci. 2022 Dec 18;23(24):16145. doi: 10.3390/ijms232416145.

3

Novel drugs targeting transthyretin amyloidosis.靶向转甲状腺素蛋白淀粉样变性的新型药物

Curr Heart Fail Rep. 2014 Mar;11(1):50-7. doi: 10.1007/s11897-013-0182-4.